Bubbles Themes Watchlists Portfolios Universe Today News Alerts Research Articles Bots About

Daily digest

One email a day · alerts + bubble shifts · free during beta.

About Alerts Research Support ♡Disclosures Terms Privacy FR PT API Follow on X

US equities · Daily close · Refreshed nightly 22:30 Paris

Not investment advice. QuantAbundancia is educational research only. Nothing on this site is a recommendation to buy, sell, or hold any security. Past performance does not guarantee future results. Full disclosures.

We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.

News

High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

2,486 signal articles · 189 in last 24h · 10,656 total before filter · latest 1h ago

189last 24h

1886last 7d

373🟢 bullish (7d)

178🔴 bearish (7d)

114publishers

All 🌍 Macro164 📊 Earnings1084 🤝 M&A81 ⚖️ Regulatory23 🚀 Product15 📈 Analyst16

✕ clear all filtersticker: MRKsentiment: neutralSentiment:bullish neutral bearish show all (incl. clickbait)

Moby1d agoneutral

Codexis, Inc. Q1 2026 Earnings Call Summary

Moby summary of Codexis, Inc.'s Q1 2026 earnings call

MRK

Healthcare Dive1d agoneutral

Federation of American Hospitals taps new government relations head

Elizabeth Schwartz will head up government relations at the for-profit hospital trade association as health systems brace for federal funding cuts.

MRK

MarketBeat1d agoneutral

Codexis Q1 Earnings Call Highlights

Codexis (NASDAQ:CDXS) reported first-quarter 2026 revenue of $15.2 million, up from $7.5 million a year earlier, as the company highlighted continued progress commercializing its ECO Synthesis enzymatic manufacturing platform for RNA medicines and reiterated full-year revenue guidance of $72 million

MRK